-
公开(公告)号:NO20024679A
公开(公告)日:2002-09-30
申请号:NO20024679
申请日:2002-09-30
Applicant: ABBOTT LAB
Inventor: DICKMAN DANIEL A , CHEMBURKAR SANJAY , FORT JAMES J , HENRY RODGER F , LECHUGA-BALLESTEROS DAVID , NIU YUPING , PORTER WILLIAM
IPC: A61K31/513 , A61P31/18 , A61P43/00 , C07D239/10
CPC classification number: C07D239/10
-
公开(公告)号:PE12322001A1
公开(公告)日:2001-12-08
申请号:PE0002992001
申请日:2001-03-30
Applicant: ABBOTT LAB
Inventor: DICKMAN DANIEL A , CHEMBURKAR SANJAY , HENRY RODGER F , NIU YUPING , PORTER WILLIAM , LECHUGA-BALLESTEROS DAVID , FORT JAMES J
IPC: A61K31/513 , A61P31/18 , A61P43/00 , C07D239/00 , C07D239/10
CPC classification number: C07D239/10
Abstract: SE REFIERE A LA FORMA CRISTALINA HIDRATADA O SOLVATADA DE LOPINAVIR (2S,3S,5S)-2-(2,6-DIMETILFENOXIACETIL)AMIN-3-HIDROXI-5-(2-(1-TETRAHIDROPIRIMID-2-ONIL)-3-METILBUTANOL)AMIN-1,6-DIFENILHEXANO) DE FORMULA I CARACTERIZADA POR PRESENTAR UN ESPECTRO INFRARROJO; UN PATRON DE DIFRACCION DE RAYOS X. EL LOPINAVIR ES UN INHIBIDOR DE PROTEASA DEL VIH
-
公开(公告)号:AU2016203198A1
公开(公告)日:2016-06-09
申请号:AU2016203198
申请日:2016-05-17
Applicant: ABBOTT LAB
Inventor: HSIAO CHU-NUNG , DHAON MADHUP , CHEN YOUNG , CHEMBURKAR SANJAY , PATEL SUBHASH , BONK PETER
IPC: C07D498/18 , A61K31/395
Abstract: ONE POT SYNTHESIS OF TETRAZOLE DERIVATIVES OF SIROLIMUS Abstract A single-step, one-pot process to obtain zotarolimus and other rapamycin derivatives on large scale that improves currently available syntheses. In one embodiment, dried rapamycin is dissolved in isopropylacetate. After cooling and 2,6-Lutidine addition, triflic anhydride is slowly added at -30'C. Salts are removed by filtration. Tetrazole, followed by a tert-base diisopropylethylamine is added. After incubation at room temperature, the product is concentrated and purified by a silica gel column using THF/heptane as eluant. The product is collected, concentrated, and purified using an acetone/heptane column. The product-containing fractions are concentrated. The product is dissolved in t-BME and precipitated with heptane. The solids are dissolved in acetone, treated with butylated-hydroxy toluene, and the solution concentrated. The process is repeated twice with acetone to remove solvents. At least one stabilizing agent is added, such as BHT at 0.5% before drying.
-
公开(公告)号:ZA200804209B
公开(公告)日:2010-08-25
申请号:ZA200804209
申请日:2006-12-12
Applicant: ABBOTT LAB
Inventor: DHAON MADHUP , HSIAO CHI-NUNG , PATEL SUBHASH , BONK PETER , CHEMBURKAR SANJAY , CHEN YONG
IPC: A61K20060101 , C07D20060101
Abstract: A single-step, one-pot process to obtain zotarolimus and other rapamycin derivatives on large scale that improves currently available syntheses. In one embodiment, dried rapamycin is dissolved in isopropylacetate. After cooling and 2,6-Lutidine addition, triflic anhydride is slowly added at -30°C. Salts are removed by filtration. Tetrazole, followed by a tert-base diisopropylethylamine is added. After incubation at room temperature, the product is concentrated and purified by a silica gel column using THF/heptane as eluant. The product is collected, concentrated, and purified using an acetone/heptane column. The product-containing fractions are concentrated. The product is dissolved in t-BME and precipitated with heptane. The solids are dissolved in acetone, treated with butylated-hydroxy toluene, and the solution concentrated. The process is repeated twice with acetone to remove solvents. At least one stabilizing agent is added, such as BHT at 0.5% before drying.
-
公开(公告)号:SA2251B1
公开(公告)日:2009-08-02
申请号:SA06270303
申请日:2001-08-07
Applicant: ABBOTT LAB
Inventor: DIECKMAN DANIEL A , CHEMBURKAR SANJAY , LECHUGA BALLESTEROS DAVID , HENRY RODGER , PORTER WILLIAM , NIU YOUPENG , FORT JAMES J
IPC: C07D239/02 , A61K20060101 , A61K31/513 , A61P20060101 , A61P31/18 , A61P43/00 , C07D20060101 , C07D239/10
Abstract: الملخص : يصفالاختراعالراهنأشكالبلورية crystalline forms جديدةمنلوبينافيرlopinavir.
-
公开(公告)号:AU2006338175A2
公开(公告)日:2009-03-12
申请号:AU2006338175
申请日:2006-12-12
Applicant: ABBOTT LAB
Inventor: HSIAO CHU-NUNG , CHEN YOUNG , BONK PETER , CHEMBURKAR SANJAY , DHAON MADHUP , PATEL SUBHASH
IPC: C07D498/18 , A61K31/395
Abstract: A single-step, one-pot process to obtain zotarolimus and other rapamycin derivatives on large scale that improves currently available syntheses. In one embodiment, dried rapamycin is dissolved in isopropylacetate. After cooling and 2,6-Lutidine addition, triflic anhydride is slowly added at -30°C. Salts are removed by filtration. Tetrazole, followed by a tert-base diisopropylethylamine is added. After incubation at room temperature, the product is concentrated and purified by a silica gel column using THF/heptane as eluant. The product is collected, concentrated, and purified using an acetone/heptane column. The product-containing fractions are concentrated. The product is dissolved in t-BME and precipitated with heptane. The solids are dissolved in acetone, treated with butylated-hydroxy toluene, and the solution concentrated. The process is repeated twice with acetone to remove solvents. At least one stabilizing agent is added, such as BHT at 0.5% before drying.
-
公开(公告)号:AR058545A1
公开(公告)日:2008-02-13
申请号:ARP060105535
申请日:2006-12-14
Applicant: ABBOTT LAB
Inventor: DHAON MADHUP , HSIAO CHU-NUNG , PATEL SUBHASH , CHEN YOUNG , CHEMBURKAR SANJAY , BONK PETER
IPC: C07D498/18 , C07D249/06 , A61K31/395 , A61P35/00 , A61P31/10 , A61P37/06 , C07D311/00 , C07D273/00 , C07D221/00
Abstract: Reivindicacion 1: Un método para preparar una molécula de formula (1) caracterizado porque comprende (a) hacer reaccionar una molécula de formula (2) con anhídrido tríflico, para producir una molécula de formula (3) y (b) hacer reaccionar la molécula de formula (3) con una molécula de formula (4) donde R1 se selecciona del grupo que consiste en =O(H, H) y (H, OH); R2 y R5 se seleccionan independientemente del grupo que consiste en H, -C(=O)R6, -C(=O)OR6, -C(=O)NHR6 y -C(=S)OR6; R3 se selecciona del grupo que consiste en =O y OR5; o R2 y R3 pueden tomarse juntos para formar una porcion de formula A-C(R7)(R8)-O-B, donde A es un enlace a un O unido al C 28 y B está unido al C 28, como se definio con anterioridad; R4 se selecciona del grupo que consiste en H y alquilo C1-4; R6 se selecciona del grupo que consiste en alquilo C1-10, cicloalquilo C3-6, grupos arilo y grupos heterocíclicos; R7 y R8 se seleccionan independientemente del grupo que consiste en H, alquilo C1-6, o R7 y R8 tomados juntos son =O; R9 y R10 se seleccionan independientemente del grupo que consiste en H, alquenilo, alquenilcicloalquenilo, alquenilcicloalquilo, alquilo, alquilcicloalquenilo, alquilcicloalquilo, alquinilo, aralquilo, arilo, cicloalquenilo, cicloalquilo, cicloalquilalquilo, cicloalquilcicloalquilo, cicloalquenilalquilo, heterociclilo, aza, amida, amonio, oxa, tia, sulfonilo, sulfinilo, sulfonamida, fosforilo, fosfinilo, fosfino, fosfonio, ceto, éster, alcohol, carbamato, urea, tiocarbonilo, boratos, boranos, boraza, sililo, siloxilo, silaza, y combinaciones de estos. Reivindicacion 2: El método de la reivindicacion 1, caracterizado porque se realiza en un solo recipiente.
-
公开(公告)号:ZA200206962B
公开(公告)日:2003-09-25
申请号:ZA200206962
申请日:2002-08-29
Applicant: ABBOTT LAB
Inventor: DICKMAN DANIEL A , FORT JAMES J , LECHUGA-BALLESTEROS DAVID , PORTER WILLIAM , CHEMBURKAR SANJAY , HENRY RODGER F , NIU YUPING
IPC: A61K20060101 , A61P20060101 , C07D20060101 , C07D , A61K , A61P
-
公开(公告)号:CZ20023529A3
公开(公告)日:2003-02-12
申请号:CZ20023529
申请日:2001-03-21
Applicant: ABBOTT LAB
Inventor: DICKMAN DANIEL A , CHEMBURKAR SANJAY , FORT JAMES J , HENRY RODGER F , LECHUGA-BALLESTEROS DAVID , NIU YUPING , PORTER WILLIAM
IPC: A61K20060101 , A61K31/513 , A61P20060101 , A61P31/18 , A61P43/00 , C07D20060101 , C07D239/10
Abstract: New crystalline forms of lopinavir are disclosed.
-
公开(公告)号:SK14832002A3
公开(公告)日:2003-02-04
申请号:SK14832002
申请日:2001-03-21
Applicant: ABBOTT LAB
Inventor: DICKMAN DANIEL A , CHEMBURKAR SANJAY , FORT JAMES J , HENRY RODGER F , LECHUGA-BALLESTEROS DAVID , NIU YUPING , PORTER WILLIAM
IPC: A61K20060101 , A61K31/513 , A61P20060101 , A61P31/18 , A61P43/00 , C07D20060101 , C07D239/10 , C07D239/00
Abstract: New crystalline forms of lopinavir are disclosed.
-
-
-
-
-
-
-
-
-